Literature DB >> 25627948

A public health perspective on the U.S. response to the Fukushima radiological emergency.

Robert C Whitcomb1, Armin J Ansari, Jennifer J Buzzell, M Carol McCurley, Charles W Miller, James M Smith, D Lynn Evans.   

Abstract

On 11 March 2011, northern Japan was struck by first a magnitude 9.0 earthquake off the eastern coast and then by an ensuing tsunami. At the Fukushima Dai-ichi Nuclear Power Plant (NPP), these twin disasters initiated a cascade of events that led to radionuclide releases. Radioactive material from Japan was subsequently transported to locations around the globe, including the U.S. The levels of radioactive material that arrived in the U.S. were never large enough to cause health effects, but the presence of this material in the environment was enough to require a response from the public health community. Events during the response illustrated some U.S. preparedness challenges that previously had been anticipated and others that were newly identified. Some of these challenges include the following: (1) Capacity, including radiation health experts, for monitoring potentially exposed people for radioactive contamination are limited and may not be adequate at the time of a large-scale radiological incident; (2) there is no public health authority to detain people contaminated with radioactive materials; (3) public health and medical capacities for response to radiation emergencies are limited; (4) public health communications regarding radiation emergencies can be improved to enhance public health response; (5) national and international exposure standards for radiation measurements (and units) and protective action guides lack uniformity; (6) access to radiation emergency monitoring data can be limited; and (7) the Strategic National Stockpile may not be currently prepared to meet the public health need for KI in the case of a surge in demand from a large-scale radiation emergency. Members of the public health community can draw on this experience to improve public health preparedness.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627948      PMCID: PMC4558551          DOI: 10.1097/HP.0000000000000198

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  5 in total

1.  Potassium iodide prophylaxis: what have we learned and questions raised by the accident at the Fukushima Daiichi Nuclear Power Plant.

Authors:  Arthur B Schneider; James M Smith
Journal:  Thyroid       Date:  2012-04       Impact factor: 6.568

2.  U.S. EPA response to the Fukushima Daiichi Nuclear Power Plant accident.

Authors:  Edward A Tupin; Michael A Boyd; Jennifer E Mosser; Jessica S Wieder
Journal:  Health Phys       Date:  2012-05       Impact factor: 1.316

3.  US screening of international travelers for radioactive contamination after the Japanese nuclear plant disaster in March 2011.

Authors:  Todd Wilson; Arthur Chang; Andre Berro; Aaron Still; Clive Brown; Andrew Demma; Jeffrey Nemhauser; Colleen Martin; Adela Salame-Alfie; Frieda Fisher-Tyler; Lee Smith; Onalee Grady-Erickson; Francisco Alvarado-Ramy; Gary Brunette; Armin Ansari; David McAdam; Nina Marano
Journal:  Disaster Med Public Health Prep       Date:  2012-10       Impact factor: 1.385

4.  Fukushima health study launched.

Authors:  Winifred A Bird
Journal:  Environ Health Perspect       Date:  2011-10       Impact factor: 9.031

5.  Study protocol for the Fukushima Health Management Survey.

Authors:  Seiji Yasumura; Mitsuaki Hosoya; Shunichi Yamashita; Kenji Kamiya; Masafumi Abe; Makoto Akashi; Kazunori Kodama; Kotaro Ozasa
Journal:  J Epidemiol       Date:  2012-08-25       Impact factor: 3.211

  5 in total
  3 in total

1.  Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency.

Authors:  Monica Schoch-Spana; Emily Brunson; Hannah Chandler; Gigi Kwik Gronvall; Sanjana Ravi; Tara Kirk Sell; Matthew P Shearer
Journal:  Public Health Rep       Date:  2018-05-30       Impact factor: 2.792

Review 2.  Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Expert Opin Pharmacother       Date:  2020-01-11       Impact factor: 3.889

3.  From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents.

Authors:  Dahlia D An; Birgitta Kullgren; Erin E Jarvis; Rebecca J Abergel
Journal:  Chem Biol Interact       Date:  2016-03-31       Impact factor: 5.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.